Becton Dickinson & Co.: Medical Device Recall in 2018 - (Recall #: Z-2869-2018)

Updated on March 25, 2026.

See the recall detail below. You can also see other recalls from the same firm in 2018.

Data Source: FDA.

Product Description:

BD BBL GC-Lect Agar; Cat. No. 297715 The device is a selective medium providing enhanced growth and recovery of Neisseria gonorrhoeae and better inhibition of contamination bacteria and fungi.

Product Classification:

Class II

Date Initiated: June 21, 2018

Date Posted: August 29, 2018

Recall Number: Z-2869-2018

Event ID: 80573

Reason for Recall:

A portion of this lot was manufactured using Gentamicin instead of Vancomycin. Gentamicin is an inhibitory agent of Neisseria organisms. This product is a selective plated medium to provide enhanced growth and recovery of N gonorrhoeae. Inhibited growth may cause a false negative result or a delayed result leading to incorrect or delayed treatment.

Status: Terminated

Product Quantity: 10,360 plates

Code Information:

8110781

Distribution Pattern:

US Distribution in states of: AK, AL, AR, AZ, CA, CO, DC, DE, FL, GA, HI, ID, IN, KS, KY, MA, MI, MS, MT, NC, JH, NY, OK, OR, PA, SC, TN, TX, WA, and WI.

Voluntary or Mandated:

Voluntary: Firm initiated